Leone D. Patterson

Insider Reports History

Entity
Individual
Signature
/s/ Alicia Hager, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leone D. Patterson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tenaya Therapeutics, Inc. Chief Fin. and Bus. Officer Common Stock 95.8K $590K $6.17 Feb 23, 2024 Direct
Tenaya Therapeutics, Inc. Chief Fin. and Bus. Officer Stock Option (Right to buy) 205K Feb 23, 2024 Direct
Nkarta, Inc. Director Stock Option (right to buy) 22.5K Jun 13, 2024 Direct
Eliem Therapeutics, Inc. Director Stock Option (Right To Buy) 10K May 19, 2022 Direct

Insider Reports Filed by Leone D. Patterson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NKTX Nkarta, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
TNYA Tenaya Therapeutics, Inc. Feb 23, 2024 2 $0 4 Feb 27, 2024 Chief Fin. and Bus. Officer
TNYA Tenaya Therapeutics, Inc. Feb 16, 2024 1 -$30.5K 4 Feb 16, 2024 Chief Fin. and Bus. Officer
TNYA Tenaya Therapeutics, Inc. Aug 16, 2023 1 -$17K 4 Aug 18, 2023 Chief Fin. and Bus. Officer
NKTX Nkarta, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
TNYA Tenaya Therapeutics, Inc. Feb 15, 2023 3 $0 4 Feb 17, 2023 Chief Fin. and Bus. Officer
NKTX Nkarta, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
ELYM Eliem Therapeutics, Inc. May 19, 2022 1 $0 4 Jun 1, 2022 Director
TNYA Tenaya Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Chief Fin. and Bus. Officer
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 9, 2021 Director
TNYA Tenaya Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Chief Fin and Bus. Officer
NKTX Nkarta, Inc. Jun 13, 2021 1 $0 4 Jun 15, 2021 Director